About Valitacell
Valitacell is a company based in Dublin (Ireland) founded in 2014 was acquired by Beckman Coulter in September 2022.. Valitacell has raised $1.45 million across 9 funding rounds from investors including Beckman Coulter, European Union and EIC Fund. Valitacell operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Dublin, Ireland
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.45 M (USD)
in 9 rounds
-
Latest Funding Round
$841.42 K (USD), Grant
Jan 01, 2020
-
Investors
Beckman Coulter
& 3 more
-
Employee Count
Employee Count
-
Acquired by
Beckman Coulter
(Sep 13, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Valitacell
Valitacell has successfully raised a total of $1.45M across 9 strategic funding rounds. The most recent funding activity was a Grant round of $841.42 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Grant — $841,423
-
First Round
First Round
(01 Jun 2016)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Grant - Valitacell | Valuation |
investors |
|
| Sep, 2019 | Amount | Grant - Valitacell | Valuation |
investors |
|
| Jun, 2019 | Amount | Grant - Valitacell | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Valitacell
Valitacell has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Beckman Coulter, European Union and EIC Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
InterTradeIreland is focused on connecting businesses across Ireland for growth.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Valitacell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Valitacell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Valitacell Comparisons
Competitors of Valitacell
Valitacell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| domain | founded_year | HQ Location |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for microbiome based diseases
|
|
| domain | founded_year | HQ Location |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| domain | founded_year | HQ Location |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Valitacell
Frequently Asked Questions about Valitacell
When was Valitacell founded?
Valitacell was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Valitacell located?
Valitacell is headquartered in Dublin, Ireland.
Is Valitacell a funded company?
Valitacell is a funded company, having raised a total of $1.45M across 9 funding rounds to date. The company's 1st funding round was a Grant of $1.27M, raised on Jun 01, 2016.
What does Valitacell do?
Valitacell was founded in 2014 in Dublin, Ireland, within the biotechnology sector focused on cell-based manufacturing. High-throughput assays are offered to enhance process efficiency, including the Fluoroprotein platform for IgG concentration measurement and the ChemStress platform for simulating bioreactor stresses on host cells. Predictions of cell performance during early development stages are enabled through these technologies, supporting biopharmaceutical production.
Who are the top competitors of Valitacell?
Valitacell's top competitors include KBI Biopharma, Aldevron and Ovagen.
Who are Valitacell's investors?
Valitacell has 4 investors. Key investors include Beckman Coulter, European Union, EIC Fund, and InterTradeIreland.